Categories: Health

Real-World Data Presented at TCT 2025 Demonstrates the EggNest Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team

SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ — At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The Christ Hospital (Cincinnati, OH) presented real-world studies¹,² demonstrating that the EggNest™ Complete Radiation Protection System from Egg Medical, Inc. (Roseville, MN) dramatically reduces radiation exposure for all members of the interventional team — including physicians, nurses, and technologists — compared to traditional shielding methods. During X-ray–guided cardiovascular procedures, scatter radiation poses a well-documented occupational hazard for Cath lab personnel, contributing to increased risks of cancer, cataracts, and cardiovascular disease. Conventional lead aprons, while offering some protection, have led to a high prevalence of orthopedic injuries among operators and staff.

- Advertisement -

In the studies presented, the average operator scatter radiation dose during coronary and PCI procedures using the EggNest Complete System was only 0.16 mRem per case. For context, the annual occupational exposure limit in the U.S. is 5,000 mRem—meaning an operator would need to perform over 31,000 cases before nearing that limit. With the typical interventionalist performing 300–500 cases annually, this technology enables a career’s worth of procedures with minimal exposure, often without the need for heavy lead aprons.

- Advertisement -

Teamwide protection was also demonstrated: nurses and technologists recorded average exposures of just 0.03 mRem per case, further confirming the EggNest System’s ability to safeguard the entire room.

- Advertisement -

“Having a radiation protection system that consistently protects my entire team as well as or better than the heavy lead we wore in the past means we’re taking care of patients and ourselves,” said Dr. Jarrod Frizzell.

- Advertisement -

Dr. Robert Riley, Chief Scientific Advisor for Egg Medical and interventional cardiologist at Overlake Medical Center (Seattle, WA), added:

- Advertisement -

“These real-world results reinforce what prior studies have shown — the EggNest Complete System is the only solution proven to significantly reduce radiation exposure for every member of the team. By enabling staff to perform procedures with ultralight or no lead aprons, we can also dramatically reduce orthopedic injuries associated with traditional protection.”

- Advertisement -

Dr. Frizzell and colleagues are continuing their evaluation of the EggNest System in structural heart and electrophysiology procedures, expanding the evidence base for its use across a broad range of X-ray–guided interventions.

- Advertisement -

References

- Advertisement -
  1. Comparison of Standard Shielding versus Next-Generation Radiation Shielding System with Light Lead Apron. Raviteja Guddeti, MD, Korey Haddox, DO, Stephen Rudick, MD, Jarrod Frizzell, MD, Christian W. Schmidt, MS, PhD, Sitaramesh Emani, MD, Timothy D. Henry, MD, Dean J. Kereiakes, MD, Robert Riley, MD, MS, Puvi Seshiah, MD, James Kong, MD, John D. Corl, MD, Samantha Tribble, RN, Becca Harper, DNP, Ashley Bias, RN, Santiago Garcia, MD. Presented October 26, 2025 at TCT 2025.
  2. Comparative Effectiveness of a Novel Scatter Radiation Shielding System Versus Standard Shielding. Jarrod Frizzell, MD, Sergey Gurevich, MD, Christian W. Schmidt, MS, PhD, Sitaramesh Emani, MD, Raviteja Guddeti, MD, Korey Haddox, DO, Robert Riley, MD, MS, Timothy D. Henry, MD, Dean J. Kereiakes, MD, James Kong,MD, Stephen Rudick, MD, Samantha Tribble, RN, Becca Harper, DNP, Ashley Bias, RN, Santiago Garcia, MD. Presented October 26, 2025 at TCT 2025.

For further information, please contact:

- Advertisement -

Egg Medical Media Contact
Susan Storm
Manager, Marketing, Egg Medical, Inc.
E-mail: sstorm@eggmedical.com 

- Advertisement -

About Egg Medical

- Advertisement -

Egg Medical is a global leader in radiation protection technologies. Headquartered in Minnesota, the company was founded with the goal to reduce the scatter radiation exposure of physicians, surgeons, nurses, technicians and others who use x-ray imaging to perform life-saving diagnostic and therapeutic procedures for patients. The EggNest Complete System provides comprehensive, table-mounted shielding that integrates seamlessly into existing workflow to protect the entire team without compromising procedural efficiency. More information about Egg Medical is available at https://eggmedical.com.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2805271/Egg_Medical_EggNest_Complete.jpg
Logo – https://mma.prnewswire.com/media/2740853/EGG_MEDICAL__Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/real-world-data-presented-at-tct-2025-demonstrates-the-eggnest-complete-radiation-protection-system-significantly-reduces-radiation-exposure-for-the-entire-cath-lab-team-302594589.html

- Advertisement -
PRNW Agency

Recent Posts

HTX Research Report Spotlights SunPerp as the Breakout Player in the 2025 Perpetual DEX Boom

PANAMA CITY, Oct. 27, 2025 /PRNewswire/ -- HTX Research, the dedicated research arm of leading…

56 minutes ago

Business Sentiment Softens in Q4 Amid Global Uncertainty, while Domestic Orders Show Continued Resilience

The Dun & Bradstreet Business Optimism Index India declined by 1.9% (q-o-q) for Q4 2025…

56 minutes ago

Humanoid Global Welcomes Saman Farid to its Investment Advisory Board

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – October…

2 hours ago

DeLeion Capital Announces Launch of Regulated Cryptocurrency Custody Plans, Marking a New Era of Secure and Intelligent Digital Asset Management

Los Angeles, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) --  DeLeion Capital today announced the launch…

2 hours ago

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a…

4 hours ago

Health Canada Grants Authorization for LEQEMBI (lecanemab) for the Treatment of Early Alzheimers Disease

In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis…

4 hours ago